| Date Filed | Type | Description |
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/28/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Unknown transaction of 3,989,130 shares
@ $9.1, valued at
$36.3M
Unknown transaction of 2,595,239 shares
@ $9.1, valued at
$23.6M
Unknown transaction of 702,505 shares
@ $9.1, valued at
$6.4M
Unknown transaction of 1,526,147 shares
@ $9.1, valued at
$13.9M
Unknown transaction of 43,139 shares
@ $9.1, valued at
$392.6k
Unknown transaction of 1,594 options to buy
@ $0
Unknown transaction of 1,250 options to buy
@ $0
Unknown transaction of 191 options to buy
@ $0
Unknown transaction of 12 options to buy
@ $0
Unknown transaction of 344 options to buy
@ $0
Unknown transaction of 239 options to buy
@ $0 |
|
| 06/12/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 05/19/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 10,967 options to buy
@ $21.39, valued at
$234.6k
|
|
| 05/12/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Disposed of 4,018,253 shares
@ $0
Disposed of 2,929,660 shares
@ $0
Disposed of 462,605 shares
@ $0
Acquired 4,018,253 options to buy
@ $0
Acquired 2,929,660 options to buy
@ $0
Acquired 462,605 options to buy
@ $0 |
|
| 05/09/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Bought 1,055,445 shares
@ $0
Bought 837,146 shares
@ $0
Bought 86,341 shares
@ $0
Bought 2,028,645 options to buy
@ $0.001, valued at
$2k
Bought 1,609,063 options to buy
@ $0.001, valued at
$1.6k
Bought 165,950 options to buy
@ $0.001, valued at
$166
Bought 3,084,090 options to buy
@ $3, valued at
$9.3M
Bought 2,446,209 options to buy
@ $3, valued at
$7.3M
Bought 252,291 options to buy
@ $3, valued at
$756.9k
|
|
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 10,961 shares
@ $29.8869, valued at
$327.6k
Bought 11,149 shares
@ $29.8869, valued at
$333.2k
Bought 2,985 shares
@ $31.2426, valued at
$93.3k
Bought 15,912 shares
@ $31.2426, valued at
$497.1k
|
|
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 6,715 shares
@ $16.497, valued at
$110.8k
Bought 3,339 shares
@ $16.8317, valued at
$56.2k
Bought 1,004 shares
@ $16.8902, valued at
$17k
Bought 9,885 shares
@ $16.497, valued at
$163.1k
Bought 3,021 shares
@ $16.8317, valued at
$50.8k
Bought 678 shares
@ $16.8902, valued at
$11.5k
|
|
| 09/16/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 26,441 shares
@ $17.2476, valued at
$456k
Bought 5,575 shares
@ $17.962, valued at
$100.1k
Bought 10,897 shares
@ $17.8873, valued at
$194.9k
Bought 13,396 shares
@ $17.8873, valued at
$239.6k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/27/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|